Coya Therapeutics’ investigational ALS therapy COYA 302 has been granted FDA Fast Track designation while the randomized, double‑blind ALSTARS Phase…
A single inner‑ear injection of AAV‑mediated gene therapy that replaces the defective OTOF gene restored measurable hearing in all ten…
Clinical trial data show solriamfetol can modestly but reliably increase wakefulness in people with shift work disorder who start work…
Novartis’ Phase III APPLAUSE‑IgAN trial published in the New England Journal of Medicine and presented at the 2026 World Congress…
Eli Lilly’s investigational triple agonist retatrutide produced large reductions in both A1C and body weight in TRANSCEND‑T2D‑1, a 537‑person Phase…
An NIH‑supported randomized trial of 140 pregnant adults with opioid use disorder found that weekly injectable extended‑release buprenorphine produced higher…
